John S. Barresi - 02 Mar 2023 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
SVP, Controller & CAO
Signature
/s/ Brianna M. Cetrulo, attorney-in-fact
Issuer symbol
BHC
Transactions as of
02 Mar 2023
Net transactions value
$0
Form type
4
Filing time
06 Mar 2023, 15:47:14 UTC
Previous filing
07 Sep 2022
Next filing
21 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Award $0 +25,266 +49% $0.000000 77,037 02 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHC Non-Qualified Stock Options (right to purchase) Award $0 +21,812 $0.000000 21,812 02 Mar 2023 Common Shares, No Par Value 21,812 $9.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
F2 The options vest in equal installments on each of the first three anniversaries of the date of grant.